Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03813836
Title Phase II Trial of Pembrolizumab in Recurrent or Metastatic HNSCC (POPPY)
Acronym POPPY
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University College, London
Indications
Therapies
Age Groups: adult | senior
Covered Countries GBR

Facility Status City State Zip Country Details
Aberdeen Royal Infirmary (NHS Grampian) Aberdeen United Kingdom Details
Bristol Haematology and Oncology Centre (University Hospital Bristol NHS Foundation Trust) Bristol United Kingdom Details
Western General Hospital (NHS Lothian) Edinburgh United Kingdom Details
East Suffolk and North Essex NHS Foundation Trust Ipswich United Kingdom Details
Guy's and St Thomas' NHS Foundation Trust London United Kingdom Details
University College London Hospital London United Kingdom Details
The Christie NHS Foundation Trust Manchester United Kingdom Details
East and North Hertfordshire NHS Trust Northwood United Kingdom Details
Queens Hospital (Barking, Havering and Redbridge University Hospitals NHS Trust) Romford United Kingdom Details
Musgrove Park Hospital (Somerset NHS Foundation Trust) Taunton United Kingdom Details
Royal Cornwall Hospital Trust Truro United Kingdom Details
The Clatterbridge Cancer Centre NHS Foundation Trust Wirral United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field